BellRing Brands (BRBR) Beats Q1 Earnings and Revenue Estimates
BellRing Brands (BRBR) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.43 per share a year ago.
BellRing Brands (BRBR) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw BellRing Brands (BRBR) settling at $79.39, representing a +1.39% change from its previous close.
BellRing Brands (BRBR) Reports Next Week: Wall Street Expects Earnings Growth
BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BellRing Brands (BRBR) Stock Sinks As Market Gains: Here's Why
The latest trading day saw BellRing Brands (BRBR) settling at $72.48, representing a -0.12% change from its previous close.
BellRing Brands (BRBR) Upgraded to Strong Buy: Here's Why
BellRing Brands (BRBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 3rd
UAA, BRBR, RBA, SRDX and CTRA have been added to the Zacks Rank #1 (Strong Buy) List on January 3, 2024.
Here's Why BellRing Brands (BRBR) Gained But Lagged the Market Today
The latest trading day saw BellRing Brands (BRBR) settling at $76.66, representing a +0.68% change from its previous close.
BellRing Brands (BRBR) Stock Falls Amid Market Uptick: What Investors Need to Know
BellRing Brands (BRBR) concluded the recent trading session at $77.93, signifying a -0.09% move from its prior day's close.
Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?
Here is how BellRing Brands (BRBR) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
BellRing Brands: Half-Time Adjustments To Secure The Lead
BellRing Brands has consistently outperformed expectations, delivering strong earnings and robust growth, particularly in its ready-to-drink shakes segment. The company's strategic initiatives, including increased production capacity and a new marketing push, aim to capitalize on rising health and wellness trends. Despite a stretched valuation compared to major consumer staples players, BRBR's high margins and operating efficiency justify its premium when compared to "niche" peers.
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
Here is how BellRing Brands (BRBR) and Durect (DRRX) have performed compared to their sector so far this year.
BellRing Brands Inc. (BRBR) Soars to 52-Week High, Time to Cash Out?
BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
